UBS O'Connor
VECT

UBS O'Connor’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

UBS O'Connor’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,847,666
Closed -$31.2M – 704
2023
Q2 		$31.2M Buy
+1,847,666
New +$24.3M 0.66% 22

Other funds holding VECT

Regency Capital Management
Regency Capital Management Honolulu, Hawaii $251M AUM 32.13% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

UBS O'Connor's VECT Position: Q3 2023 in Review

UBS O'Connor sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 1,847,666 shares — an estimated $31.2M sold.

UBS O'Connor first reported a position in VECT in Q2 2023 and held it in 1 quarter. The position peaked at $31.2M in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

  • UBS O'Connor reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • UBS O'Connor sold 1,847,666 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $31.2M.
  • UBS O'Connor first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2023 and held it in 1 quarter.
  • UBS O'Connor's VectivBio Holding AG Ordinary Shares position peaked at $31.2M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.